Enhanced CD56 Expression and Increased Number of CD56 <sup>+bright</sup> Cells in the Peripheral Blood of Untreated Endometriosis Patients
The significantly increased proportion of peripheral CD56<sup>+bright </sup>NK/eNK cells may result from migration of these cells from ectopic endometrial tissue. The downregulation of NKG2D receptor expression in PBMCs may be mediated by immunosuppressive endometriotic exosomes, as previously reported by us. Taken together, our results suggest that: (1) the impaired NK cell cytotoxicity in untreated endometriosis patients may be due both to an influx of CD56<sup>+bright</sup>/eNK cells and exosome-induced NKG2D receptor downregulation; and (2) elevated numbers of peripheral CD56<sup>+bright</sup> NK cells could be considered as a potential diagnostic marker for endometriosis.
Authors
- Olga Nagaeva
- Ulrika Ottander (ORCID: https://orcid.org/0000-0002-1383-7753)
- Pernilla Israelsson (ORCID: https://orcid.org/0009-0003-8605-8122)
- Lucia Mincheva‐Nilsson
- Emma Björk
Institutions
- Ornsköldsvik Hospital (SE)
- Umeå University (SE)
Publication Details
- Journal
- American Journal of Reproductive Immunology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/aji.70214
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancerfonden
- Västerbotten Läns Landsting
- Vetenskapsrådet
- Umeå Universitet
- Cancer Research Foundation in Northern Sweden
- Medicinska fakulteten, Umeå Universitet